Hong Wan, PhD

President, CEO and Co-Founder at Tallac Therapeutics

Speaker

Hong I. Wan, Ph.D. is a scientist, drug developer, executive and entrepreneur, with 25+ years in the industry shepherding 20+ NMEs into clinical development. A versatile leader and company builder, she has held executive and C-level roles in large Pharma and biotech startups. She is a Scientific Advisor to Lightstone Ventures and a member of the Biotech CEO Sisterhood. She co-founded and was the president and chief executive officer of Tallac Therapeutics, a clinical stage biotech company developing novel antibody-oligonucleotide conjugates for oncology. Previously she served as chief scientific officer and a member of the founding management at ALX Oncology, a publicly traded immuno-oncology company. During her earlier career, Hong held various leadership positions at Pfizer and Wyeth Research, where she was responsible for the early development and translational medicine strategy and execution across various therapeutic areas. Hong received her Ph.D. in molecular and cell biology from University of California, Berkeley and A.B. degree in biochemical sciences from Harvard University.